Table 4

Summary of noncompartmental analysis of plasma and lymph data in pigs receiving PEG-IL-24-a

RegimenDosePlasma DataLymph DataAUCL/AUCP4-a
AUCP4-aCL/F4-a4-bVss/F4-a4-cMRT4-dt1/24-dAUCL4-at1/24-d
MIU/kg ng · h/ml I.U. · h/ml4-e ml/h/kg ml/kg h ng · h/ml I.U. · h/ml4-e h
i.v. 15-min infusion0.01249  ± 24 (10)99610.1  ± 1.0 (10)82.4  ± 8.4 (10)8.256.2982.4  ± 10.7 (13)3307.190.33  ± 0.07 (22)
s.c. bolus0.01403  ± 148 (37)16127.07  ± 3.29 (46)240  ± 66 (27)32.421.8467  ± 424 (91)186812.51.20  ± 0.99 (83)
s.c. bolus0.03932  ± 431 (46)37289.09  ± 3.39 (37)301  ± 77 (26)23.714.4962  ± 69 (7)384810.21.18  ± 0.49 (41)
s.c. bolus0.11494  ± 671 (45)597619.7  ± 9.1 (46)4-150 415  ± 212 (51)4-150 22.813.11856  ± 504 (27)742410.71.36  ± 0.42 (31)
  • 4-a Data are mean ± S.D.; numbers in parentheses represent coefficient of variation as a percentage.

  • 4-b CL/F significantly different when stratified by route and dose level (P = .04).

  • 4-c Vss/F was significantly different when stratified by route and dose level (P = .04).

  • 4-d Harmonic mean is reported for MRT and half-life.

  • 4-e A specific activity of 4 MIU/mg was used to convert the PEG-IL-2 data from mass units (mg) to activity units (I.U.).

  • 4-150  Comparisons of all pairs using Tukey-Kramer HSD showed that mean values for s.c. bolus, dose level 0.1 MIU/kg, was significantly different from the 0.01 MIU/kg for CL/F. For Vss/F, the mean for s.c. bolus, dose level 0.1 MIU/kg, was significantly different from the i.v. 15-min infusion dose group.